SHELLEY MCCLURE: Open Payments
NPI 1184392649 · NORMAN, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$886 in 41 payments from 12 companies in 2025. Trend: 2023 $66 · 2024 $305 · 2025 $886
Food & beverage: $844Education: $43
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics | 11 | $310 |
| Xeris Pharmaceuticals, Inc. | 13 | $198 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $86 |
| Mannkind Corporation | 2 | $70 |
| Madrigal Pharmaceuticals | 3 | $70 |
| Antares Pharma, Inc. | 2 | $35 |
| Echosens North America, Inc. | 1 | $25 |
| Alexion Pharmaceuticals, Inc. | 1 | $20 |
| Medtronic, Inc. | 1 | $19 |
| Rhythm Pharmaceuticals, Inc. | 1 | $19 |
Products named: Korlym, RECORLEV, Kerendia, AFREZZA, REZDIFFRA, XYOSTED, Fibroscan, STRENSIQ.
Industry payments across OK — which companies pay providers there.
